Mevion Medical wins FDA 510(k) clearance for Mevion S250 proton therapy systems
Allied Healthcare Products
FDA review sends BioMimetic shares plunging despite solid Q1 growth | Earnings roundup
Shares of BioMimetic Therapeutics Inc. (NSDQ:BMTI) continued their slide today after plummeting 35.3 percent yesterday to close at $8.66 on news of the FDA’s dim view of its Augment bone graft product.
Allied Healthcare swings to Q2 profits
Allied Healthcare Products (NSDQ:AHPI) posted second-quarter sales of $11.4 million for the three months ended Dec. 31, 2009, down 8.9 percent compared with $12.5 million during the same period in fiscal 2009. Allied Healthcare swung to net income of $21,600 during the quarter, compared with a net loss of $436,100 during Q2 2009: